DANIELLE BOSSCHER: Open Payments
NPI 1871040154 · BIRMINGHAM, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 97 payments from 15 companies in 2025. Trend: 2023 $2,495 · 2024 $1,559 · 2025 $1,654
Food & beverage: $1,644Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $591 |
| Incyte Corporation | 13 | $191 |
| E.R. Squibb & Sons, L.L.C. | 17 | $174 |
| Novartis Pharmaceuticals Corporation | 11 | $160 |
| UCB, Inc. | 2 | $148 |
| ABBVIE INC. | 10 | $140 |
| Organon LLC | 3 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| LEO Pharma Inc. | 2 | $34 |
Products named: TREMFYA, OPZELURA, Sotyktu, Bimzelx, COSENTYX, SKYRIZI, RINVOQ, Zoryve.
Industry payments across MI — which companies pay providers there.
